Gene editing may not be the safest HIV cure strategy, early findings warn

Gene editing technologies are being explored as a potential cure for HIV. CRISPR/Cas9 is a gene editing technology that is precise in finding its target, but the DNA repair process following the editing seems to be inefficient. This inefficiency can lead to changes in our DNA (mutations) that can potentially increase the risk of diseases, particularly cancer later in life. More research is needed to determine the safety and efficacy of CRISPR/Cas9 for HIV gene therapy. By Coshorts